Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIMNW
#11861
Liminatus Pharma, Inc. Class A Common Stock
0.061
6
USD
+2.50%
Sector:
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.50%
Monthly Change
-58.21%
6 month change
-65.30%
Year Change
-65.78%
Previous Close
0.060
1
Open
0.061
6
Bid
Ask
Low
0.061
6
High
0.061
6
Volume
1
Markets
US Stock Market
LIMNW
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2025
TTM
Key stats
Total common shares outstanding
44.88 M
—
Valuation ratios
Enterprise value
—
—
Price to earnings ratio
-0.08
—
Price to sales ratio
—
—
Price to cash flow ratio
-0.08
—
Price to book ratio
-0.08
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-19.9
—
Return on equity %
1.04
2.17
Return on invested capital %
-94.56
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
0.05
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
-0.42
-0.42
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
0.01
—
Net current asset value per share
0.02
—
Tangible book value per share
-0.41
-11.45
Working capital per share
-0.41
—
Book value per share
-0.41
-11.45